Detalles de la búsqueda
1.
Development and validation of a prediction model for the risk of developing febrile neutropenia in the first cycle of chemotherapy among elderly patients with breast, lung, colorectal, and prostate cancer.
Support Care Cancer
; 19(3): 333-41, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20179995
2.
Immunotherapy-associated complete heart block in a patient with NSCLC: A case report and literature review.
Respir Med Case Rep
; 33: 101390, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33786301
3.
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis.
Clin Lung Cancer
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744613
4.
Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.
J Cancer Res Clin Oncol
; 140(3): 443-52, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24442098
5.
Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer.
J Thorac Oncol
; 8(3): 270-8, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23399957
6.
The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth.
Mol Cancer Ther
; 12(6): 890-900, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23493311
7.
Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines.
Mol Cancer Ther
; 9(7): 1985-94, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20587667
8.
Novel drugs--miscellaneous category.
J Thorac Oncol
; 5(12 Suppl 6): S468-9, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21102242
Resultados
1 -
8
de 8
1
Próxima >
>>